←
John Vandermosten8,090 posts
John Vandermosten avatar

John Vandermosten

@vanjohn10

Biotechnology Analyst, CFA. Cancer, Autoimmune and Neurodegenerative Diseases. Audaces fortuna iuvat.

◷ Joined April 2009
John Vandermosten avatar
John Vandermosten@vanjohn10·8h

Nasus Pharma presented NS002 data @ ACAAI showing faster time to therapeutic threshold vs epinephrine autoinjector. Under conditions of: *Repeat dosing *Severe nasal congestion ~Allergist survey results also presented on importance of speed ~12-16Nov $NSRX finance.yahoo.com/healthcare…

John Vandermosten avatar
John Vandermosten@vanjohn10·Nov 13

TuHURA reports 3Q *Presentations @ ASH on Delta Opioid Receptor *Milestone update provided $HURA finance.yahoo.com/healthcare…

John Vandermosten avatar
John Vandermosten@vanjohn10·Nov 10

Spectral AI reports 3Q *Revs $2.9mm vs our $5.7mm *Loss of 11c/sh vs our 9c *On track for initial DeepView deliveries in 4Q26 *Reducing revenue guidance to $13mm from $18.5mm due to no additional contracting opportunities for the MTEC program in 2026 *Call @ 5 pm ET $MDAI tinyurl.com/3r5rsa5v

John Vandermosten avatar
John Vandermosten@vanjohn10·Nov 10

Spectral AI reports 3Q *On track for initial DeepView deliveries in 4Q26 *Reducing revenue guidance to $13mm from $18.5mm due to no additional contracting opportunities for the MTEC program in 2026 *Call @ 5 pm ET $MDAI finance.yahoo.com/technology…

John Vandermosten avatar
John Vandermosten@vanjohn10·Nov 10

Nasus Pharma announced abstracts for NS002 *Accepted for presentation @ ACAAI *12-16Nov *Enhanced Absorption of Intranasal Powder Epinephrine after Single Dose in Adults with Allergic Rhinitis + others *Drs Blaiss, Megiddo & Fleicher + CEO O'Grady presenting $NSRX finance.yahoo.com/healthcare…

John Vandermosten avatar
John Vandermosten@vanjohn10·Nov 9

AEON Biopharma submits IND for comparative pharmacodynamic study of ABP-450. See the associated clip for details on how the FDA will evaluate it. $AEON finance.yahoo.com/healthcare…

AEON Biopharma CEO Rob Bancroft shares some of the tools the FDA is using to evaluate biosimilarity. $AEON #BiotechStocks #Investing #BioTech #Biosimilars #Investors #ABP450 #BotoxBiosimilar #FDAApproval youtube.com/shorts/zT65kgClF…

John Vandermosten avatar
John Vandermosten@vanjohn10·Nov 9

Achieve Life Sciences (@achievelifesci) becomes AchieveRx *Will trade under ticker solana:HSHJ3t4Vu3B1qMs9Nv5iKUaoPMQQf1VuT5vVaTvLqc6p on NASDAQ ~Effective 10Nov26 *Website to change to achieverx.com *Emphasizes focus on quitting both smoking & vaping $ACHV achieverx.com/achieve-life-s…

John Vandermosten avatar
John Vandermosten@vanjohn10·Nov 5

For all of those who are fans of Issac Asimov and enjoyed the movies I, Robot and the Foundation series as well as embrace the concept of psychohistory, here is a 1987 28-minute interview with the science fiction writer: freshairarchive.org/segments…